JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB134175

Anti-Cyclin D1 antibody [EPR2241] - C-terminal

  • 20ul selling size
  • BOND RX™ Validated
  • KO Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • What is this?

5

(15 Reviews)

|

(957 Publications)

Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) is a rabbit monoclonal antibody detecting Cyclin D1 in Western Blot, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 780 publications

View Alternative Names

BCL1, PRAD1, CCND1, G1/S-specific cyclin-D1, B-cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene, BCL-1

17 Images
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • WB

Lab

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Western blot : Anti-CCND1 antibody [EPR2241] (ab134175) staining at 1/10000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab134175 was shown to bind specifically to CCND1. A band was observed at 34 kDa in wild-type A549 cell lysates with no signal observed at this size in CCND1 knockout cell line. To generate this image, wild-type and CCND1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/10000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

CCND1 knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human CCND1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-ccnd1-knockout-a549-cell-line-ab286759'>ab286759</a>)

Lane 3:

SH-SY5Y cell lysate at 20 µg

Lane 4:

K562 cell lysate at 20 µg

false

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Immunofluorescent staining of Ramos (Human Burkitt's lymphoma cell line) cells (fixed in 4% PFA, permeabilized with 0.1% Triton X 100) using purified ab134175 at a dilution of 1/50. An Alexa Fluor® 488 goat anti-rabbit antibody was used as the secondary at a dilution of 1/500 and the cells were counterstained with DAPI.

The negative control is shown in the bottom right hand panel - for the negative control, Alex Fluor® 594 goat anti-mouse was used at a dilution of 1/500.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

IHC image of ab134175 staining Cyclin D1 in human esophagus formalin fixed paraffin embedded tissue sections*, performed on a Leica Bond. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab134175, 5μg/ml working concentration, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with hematoxylin and mounted with DPX. No primary antibody was used in the secondary only control (shown on the inset).
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Immunohistochemical staining of paraffin embedded human endometrial adenocarcinoma with purified ab134175 at a dilution of 1/100. An HRP goat anti-rabbit (ab97051) was used as the secondary antibody at a dilution of 1/500 and the sample was counterstained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0.

PBS was used instead of the primary antibody as the negative control (inset).

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Unpurified ab134175 staining Cyclin D1 in MCF7 (Human breast adenocarcinoma cell line) cells treated with KN-93 (ab120980).

The cells were fixed with 100% methanol (5min) and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated with ab134175 at 10μg/ml and ab7291 at 1μg/ml overnight at +4°C, followed by a further incubation at room temperature for 1h with an Goat anti-Rabbit Alexa 488 secondary (ab150081) at 2 μg/ml (shown in green) and Goat anti-Mouse Alexa 594 secondary (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labeled in blue with DAPI.

Negative controls : 1– Rabbit primary and anti-mouse secondary antibody; 2 – Mouse primary antibody and anti-rabbit secondary antibody. Controls 1 and 2 indicate that there is no unspecific reaction between primary and secondary antibodies used.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Immunohistochemistry was performed on human head and neck squamous cell carcinoma tissue using a rabbit monoclonal antibody against the CCND1 protein ab134175 on 3-μm slides using 224 paraffin sections via the standard SP method.

Panel C : An example of low Cyclin D1 expression.

Panel G : An example of high Cyclin D1 expression.

For full image please see paper.

Feng et al PLoS One. 2011;6(10):e26399. doi: 10.1371/journal.pone.0026399. Epub 2011 Oct 31. Fig 1. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • ICC/IF

AbReview40418****

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Immunocytochemical analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells, labeling Cyclin D1 with ab134175 at a dilution of 1/200. Cells were paraformaldehyde fixed and permeabilized with 0.5% Triton X-100 in PBS. Incubation with the primary antibody was for 1 hour at 22°C. Cells were counterstained with DAPI following immunostaining.

This image is courtesy of an Abreview submitted by Kirk Mcmanus.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Immunohistochemical analysis of paraffin-embedded human mantle cell lymphoma tissue, labeling Cyclin D1 with unpurified ab134175 at 1/100 dilution.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling Cyclin D1 with ab134175 at a concentration of 1 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

Anti-Cyclin D1 antibody [EPR2241] ab134175 was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunoprecipitation - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IP

Lab

Immunoprecipitation - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

ab134175 (purified) at 1/30 immunoprecipitating cyclin D1 in A431 (Human epidermoid carcinoma cell line) cells. For western blotting, an HRP-conjugated goat anti-rabbit IgG, was used as the secondary antibody (1/1000).

Blocking/Dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175)

Predicted band size: 34 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

IHC image of ab134175 staining Cyclin D1 in rat esophagus formalin fixed paraffin embedded tissue sections, performed on a Leica Bond. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab134175, 5μg/ml working concentration, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with hematoxylin and mounted with DPX. No primary antibody was used in the secondary only control (shown on the inset).
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • WB

Lab

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/100000 dilution

Lane 1:

MCF7 (Human breast adenocarcinoma cell line) cell lysate at 20 µg

Lane 2:

LNCap (Human prostate cancer cell line) cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 34 kDa

Observed band size: 34 kDa

false

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • WB

Unknown

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

MG-63 cells were incubated at 37°C for 24h with vehicle control (0 μM) and different concentrations of 3-aminobenzamide (3-AB) (ab141069). Decreased expression of cyclin D1 (unpurified ab134175) in MG-63 cells correlates with an increase in 3-aminobenzamide (3-AB) concentration, as described in literature.

Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with unpurified ab134175 at 1/500 dilution and ab8226 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit HRP secondary antibody (ab97051) at 1/10000 dilution and visualised using ECL development solution.

All lanes:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175)

Predicted band size: 34 kDa

true

Exposure time: 3min

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • WB

Lab

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/20000 dilution

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg

Lane 2:

A431 (Human epidermoid carcinoma cell line) cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 34 kDa

Observed band size: 34 kDa

false

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • WB

Lab

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/10000 dilution

Lane 1:

Mouse kidney at 20 µg

Lane 2:

Mouse spleen at 20 µg

Lane 3:

Rat heart at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 34 kDa

Observed band size: 34 kDa

false

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • WB

Lab

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

Blocking and dilution buffer : 5% NFDM/TBST.

Lane 1:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 0.04 µg/mL

Lane 2:

Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 2 µg/mL

Lane 1:

His-Tagged full-length human Cyclin D1 (aa 1 to 295) recombinant protein at 0.015 µg

Lane 2:

His-Tagged full-length human Cyclin D2 (aa 1 to 289) recombinant protein at 0.015 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 34 kDa

Observed band size: 37 kDa

false

Exposure time: 3min

OI-RD Scanning - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2241

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, ICC/IF, IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

<p>The immunogen used for this product shares 66% homology with CCND2 (seven amino acid stretch with 100% homology). Based on internal testing in WB, this product shows a weak cross-reactivity to Cyclin D2&#46; For IHC usage, this product shows a tissue localization specific to Cyclin D1 with no cross-reactivity to Cyclin D2&#46;</p>

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p>Compared to the working concentration with cyclin D1 recombinant protein, a 50 fold increase is required with cyclin D2 recombinant protein in western blot testing.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p>Compared to the working concentration with cyclin D1 recombinant protein, a 50 fold increase is required with cyclin D2 recombinant protein in western blot testing.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Product Specifications
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, IP, WB in human, mouse, rat samples.
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) specifically detects Cyclin D1 (UniProt ID: P24385; Molecular weight: 34kDa) and is sold in 50 µL, 100 µL and 1 mL selling sizes.

Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has been confirmed by testing in knockout samples.
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has been cited over 783 times in peer reviewed journals and is trusted by the scientific community.
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has 15 independent reviews from customers.

Related Products
Antibody clone EPR2241 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP, Alexa Fluor® 594, Alexa Fluor® 555 (ab190194, ab190563, ab190564, ab203446, ab203448).

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 33854235, PubMed : 8114739, PubMed : 8302605). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 8114739, PubMed : 8302605). Hypophosphorylates RB1 in early G(1) phase (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 8114739, PubMed : 8302605). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 8302605). Also a substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity (PubMed : 15241418). Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (PubMed : 9106657). Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner (PubMed : 16569215, PubMed : 18417529).
See full target information CCND1

Publications (957)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in bioengineering and biotechnology 13:1641476 PubMed41069411

2025

CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis in distraction osteogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Yimurang Hamiti,Kai Liu,Sulong Wang,Xin Yang,Xiriaili Kadier,Aihemaitijiang Yusufu

Cancer management and research 17:1989-1997 PubMed41019940

2025

Neuropilin-2 Mediates Radioresistance in Nasopharyngeal Carcinoma via Wnt/β-Catenin Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jiawei Chen,Huimin Fu,Xiaopeng Huang,Zetan Chen

OncoTargets and therapy 18:979-994 PubMed40934061

2025

The Dual Role of RBBP7 in Esophageal Squamous Cell Carcinoma: Cell Context-Dependent Impacts on Proliferation and Radiosensitivity.

Applications

Unspecified application

Species

Unspecified reactive species

Yafen Li,Shuai Lu,Hui Yao,Genbao Zhu,Hao Liu,Zhiyu Ma,Heng Tang

Molecular and clinical oncology 23:95 PubMed40901568

2025

Silvestrol inhibits nasopharyngeal carcinoma cells and synergizes with CX-5461: Insights from a proteomics study.

Applications

Unspecified application

Species

Unspecified reactive species

Maelinda Daker,Munirah Ahmad,Alan Soo-Beng Khoo,Lu Ping Tan,Siok-Fong Chin,Siaw San Hwang,Paul M Neilsen

Materials today. Bio 34:102181 PubMed40893374

2025

CGRP-releasing PLGA/nHA/GO composite microspheres enhance distraction osteogenesis via activation of the cAMP/PKA/CREB pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yimurang Hamiti,Kai Liu,Xin Yang,Sulong Wang,Xiriaili Kadier,Aihemaitijiang Yusufu

Exploration (Beijing, China) 5:20240363 PubMed40873647

2025

Suppresses CD8 T Cell Effector Function and Intestinal Inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Yingying Lin,Yuqi Wang,Yuning Zhang,Yao Lu,Juan Chen,Yongting Luo,Jian He,Qingfeng Luo,Heng Quan,Weiru Yu,Yujia Luo,Peng Xue,Yi Xue,Xiaoya Lin,Rui Ding,Lining Chen,Yiran Wang,Zenghui Xia,Liang Zhao,Hao Zhang,Ran Wang,Qingyu Wang,Xifan Wang,Jiaqi Su,Fazheng Ren,Cong Lv,Yixuan Li,Huiyuan Guo

Cancer management and research 17:1657-1666 PubMed40837329

2025

Erianin Suppresses Pancreatic Cancer Progression by Inducing Cell Cycle Arrest and Ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao Qu,Bin He,Yaohui Zhang,Li Hang,Ping Lu

American journal of cancer research 15:2949-2969 PubMed40814362

2025

Increased autophagy activity suppresses hyperglycemia-related colorectal cancer tumorigenesis both and .

Applications

Unspecified application

Species

Unspecified reactive species

Pei-Wen Lin,Yu-Wen Liu,Man-Ling Chu,Chien-An Chu,Chung-Ta Lee,Yao-Hsiang Shih,Sheng-Hui Lan,Shang-Ying Wu,Hong-Yi Chang,Wei-Chung Chen,I-Chen Wu,Li-Tzong Chen,Ming-Yii Huang,Jaw-Yuan Wang,Ying-Ray Lee,Hsiao-Sheng Liu

International journal of molecular sciences 26: PubMed40806270

2025

Chemosensitizer Effects of Cisplatin- and 5-Fluorouracil-Treated Hepatocellular Carcinomas by Lidocaine.

Applications

Unspecified application

Species

Unspecified reactive species

Teng-Wei Chen,Hsiu-Lung Fan,Shu-Ting Liu,Shih-Ming Huang

BMC cancer 25:1313 PubMed40804612

2025

CircMORC1 downregulated in plasma EVs promotes gastric cancer cell proliferation and invasion via miR-103a-1-5p sponging.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang-Ming Zhai,Yi-Qi Yang,Li Lin,Huan-Chang Luo,Zhi-Wei Guo,Ying-Song Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com